Comment on: Intravenous immunoglobulin for interstitial lung diseases of antimelanoma differentiation-associated gene 5-positive dermatomyositis: Reply

Rheumatology (Oxford). 2022 Aug 30;61(9):e284-e285. doi: 10.1093/rheumatology/keac122.

Authors

Li-Mei Wang¹, Qi-Hua Yang¹, Lei Zhang¹, Sheng-Yun Liu¹, Pan-Pan Zhang¹, Xin Zhang¹, Xiao-Jun Liu¹, Li-Shuai Han¹, Tian-Fang Li¹

Affiliation

¹ Department of Rheumatology and Immunology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China.

PMID: 35258590
DOI: 10.1093/rheumatology/keac122

No abstract available

Publication types

Research Support, Non-U.S. Gov't
Letter
Comment

MeSH terms

Autoantibodies
Dermatomyositis* / drug therapy
Dermatomyositis* / genetics
Humans
Immunoglobulins, Intravenous / therapeutic use
Interferon-Induced Helicase, IFIH1 / genetics
Lung Diseases, Interstitial* / drug therapy
Lung Diseases, Interstitial* / genetics

Substances

Autoantibodies
Immunoglobulins, Intravenous
Interferon-Induced Helicase, IFIH1